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Analogue-sensitive (as) mutants of kinases arewidely used to selectively inhibit a
single kinase with few off-target effects. The analogue-sensitive mutant cdc2-as of
fission yeast (Schizosaccharomyces pombe) is a powerful tool to study the cell cycle,
but the strain displays meiotic defects, and is sensitive to high and low tempera-
ture even in the absence of ATP-analogue inhibitors. This has limited the use of
the strain for use in these settings. Here, we used in vivo selection for intragenic
suppressor mutations of cdc2-as that restore full function in the absence of ATP-
analogues. The cdc2-asM17 underwent meiosis and produced viable spores to a
similar degree to the wild-type strain. The suppressor mutation also rescued
the sensitivity of the cdc2-as strain to high and low temperature, genotoxins and
an anti-microtubule drug. We have used cdc2-asM17 to show that Cdc2 activity
is required to maintain the activity of the spindle assembly checkpoint. Further-
more, we also demonstrate that maintenance of the Shugoshin Sgo1 at meiotic
centromeres does not require Cdc2 activity, whereas localization of the kinase
aurora does. The modified cdc2-asM17 allele can be thus used to analyse many
aspects of cell-cycle-related events in fission yeast.2. Introduction
Phosphorylation is involved in many cellular events, often serving as a molecular
switch to regulate signallingpathways. The fissionyeast genomecontains 96protein
kinases (www.pombase.org [1]). A variety of genetic materials and methods have
been developed to investigate the function of each kinase in Schizosaccharomyces
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common to use conditional mutants to knockdown the gene
function. Those include temperature-sensitive (ts) mutants,
which lose functions at the restrictive temperature. Although
this method provides a powerful genetic tool, it poses practical
problems for cell biology. For instance, it is difficult to reduce
kinase activity rapidly during live-cell imaging because of the
technical difficulties involved in changing the temperature. Fur-
thermore, most mutants are not well characterized with regard
to how fast the activity is lost following shift to the restrictive
temperature. Small molecules are frequently used as kinase
inhibitors, particularly for the analysis of cultured mammalian
cells; however, many of these work poorly on yeast cells (for
example, fig. 1 of [2]).
These technical difficulties were solved by a so-called
chemical genetics approach [3]. Substitution of a single amino
acid in the adenosine triphosphate (ATP)-binding pocket of a
kinase (the so-called gatekeeper residue) renders the mutant
kinase sensitive to ATP-analogue molecules that cannot fit
into the active site of an unmodified kinase. This confers speci-
ficity to the inhibitor, as genetically unmodified kinases are
unaffected byATP-analogues. They also inhibit the kinase func-
tion rapidly (approximatelyminutes after a drug addition to the
medium [4]), permitting time-lapse observation over short
time scales. In principle, the gatekeeper residue of any kinase
can be predicted from its amino acid sequence [5,6], which
has prompted the construction of an as-mutant collection of
fission yeast essential kinases [7]. Analogue-sensitive mutants
are now widely used for analyses of cell cycle regulation.
Mitotic progression is controlled by protein kinases that
have been conserved from yeast to human [8]. The main
mitotic kinases include cyclin-dependent kinase 1 (Cdk1),
known as Cdc2 in fission yeast and Cdc28 in budding yeast
[9–11]; the polo kinase, known as Plo1 in fission yeast and
Cdc5 in budding yeast [12–14]; and the single aurora
kinase (equivalent to aurora B), which is known as Ark1 in
fission yeast and Ipl1 in budding yeast [15,16]. Analogue-
sensitive mutants of these mitotic kinases have been described:
fission yeast cdc2-as [17] and budding yeast cdc28-as1 [3] for
Cdk1; cdc5-as [18] and plo1-as [7] for polo kinase; and
ark1-as2/as3 [19] and ipl1-as [5] for aurora B kinase.
Cdc2/Cdc28 regulates both the G1/S andG2/M transitions
in S. pombe and Saccharomyces cerevisiae. Comprehensive proteo-
mics analyses using cdc28-as1 in budding yeast have identified
more than 300 Cdk1 substrates [4,20]. In S. pombe, Cdc2 is
required both for the G1/S and G2/M transitions (for review,
see [21]). Many mitotic substrates have been identified; for
example, Cdc2 is required for activation of Plo1 [22], for faithful
chromosome segregation through controlling localization of the
chromosomal passenger complex (CPC) [23] and Nsk1 [24], for
chromosome condensation through nuclear accumulation of
the condensin Cut3/SMC4 [25,26], and for localization of the
microtubule-associated protein (MAP) Dis1/tumour overex-
pressed gene (TOG) at kinetochores [27,28]. Cdc2 is also
required for activation of the anaphase-promoting complex
(APC/cyclosome) [29–31].
Combining analogue-sensitive mutants of mitotic kinases
with microscopy of living cells provides a way to investigate
kinase function during short periods of the cell cycle (e.g.meta-
phase or anaphase): addition of the inhibitory analogue
decreases the activity of the kinase rapidly, to the extent desired
[17,32]. This approach has revealed that Cdc2 is required for the
nuclear accumulation of theMAP complex Alp7/transformingacidic coiled-coil-Alp14/TOG in early stages of mitosis, which
facilitates bipolar spindle assembly [33–35], and in latemitosis,
downregulation of Cdc2 promotes the asymmetric localization
of septum initiation network proteins at spindle pole bodies
(SPBs, the centrosome equivalent in yeast) [17,36].
Although analogue-sensitivemutants can be easilymade by
substitution of the gatekeeper amino acid, this mutation
occasionally has deleterious effects. The fission yeast cdc2-as
mutant is generatedby theF84Gmutation.However, inaddition
to analogue sensitivity, the cells are elongated at 258C, indicating
a delay in mitotic commitment, and they are also heat-sensitive,
particularly at 368C, even in the absence of the ATP-analogue
molecule [17]. In addition, the cdc2-as mutant is defective in
sexual differentiation (mating and meiosis) and the mutant
zygotes produce two-spore asci instead of four-spore ones of
thewild-type zygotes [17]. Suchphenotypeshavebeenobserved
in other hypomorphic alleles of Cdc2 [37–39] and the meiotic
mutant cdc2-N22/tws1 [40,41], indicating that the gatekeeper
mutation reducesCdc2–Cdc13activity per se. This limits theuse-
fulness of the cdc2-asallele in certain circumstances. For example,
it is difficult to combine cdc2-as with many heat-sensitive
mutants that require incubation at 368C to arrest efficiently
(e.g. cdc25–22 [42]); cdc2-as also shows a negative interaction
with mutants that arrest in mitosis, such as the b-tubulin
mutants nda3-311 (cs) and nda3/alp12-1828 (ts) [43–45]. This
incompatibility of the cdc2-as mutation with key mutants used
to impose cell cycle arrests limits its utility for the analysis of
some mitotic functions of Cdc2–Cdc13.
Meiosis in fission yeast consists of pre-meiotic DNA repli-
cation, meiotic recombination during meiotic prophase, and
two consecutive rounds of chromosome segregation (meiosis
I and meiosis II) without an intervening S phase, prior to spor-
ulation. To achieve this meiosis-specific cell cycle progression,
the Cdc2 activity is regulated in a special manner during meio-
sis. A fraction of Cdc13/cyclin B is protected from degradation
even after anaphase onset of meiosis I to provide CDK activity
for the onset of meiosis II [46]; this contrasts with the situation
in mitosis, where Cdc13 is entirely degraded at anaphase
onset. Degradation of Cdc13 by the APC/cyclosome is inhib-
ited by Mes1 after anaphase onset of meiosis I [46], whereas
CDK must be fully inactivated after meiosis II to avoid ‘meio-
sis III’ [47]. The unique modulation of Cdc2–Cdc13 implies
that the function of Cdc2 in meiosis may differ from that in
mitosis. The multiple roles of Cdc2 in meiosis have limited
the use of conditional mutants to analyse its function. The
existing cdc2-as mutant is also limited in its suitability for
studies in meiosis, owing to production of dyads, in contrast
to tetrads that wild-type zygotes produce [17].
Thus, although the previously described cdc2-asmutant is
a powerful tool, it also has technical limitations in some
experimental settings. We therefore decided to use natural
selection to modify the cdc2-as allele to eliminate the undesir-
able hypomorphic phenotypes by additional mutations. We
have used this improved cdc2-as allele to examine various
functions of cdc2 during mitosis and meiosis.3. Results and discussion
3.1. Isolation of intragenic suppressor mutants of cdc2-as
The original cdc2-as mutant gene contains a single amino
acid substitution (F84G) at the gatekeeper residue [17]
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Figure 1. Characterization of the cdc2-asM17 mutant in mitotic cell cycle. (a) Schematic of wild-type cdc2 (WT), cdc2-as (as), cdc2-asM17 (asM17) and cdc2-
asM17 þ bsd (asM17 þ bsd) mutant genes. The bsd marker was inserted in the downstream of the cdc2 coding sequence. (b) Calcofluor staining of vegetative
cells at 258C. Scale bar, 10 mm. The scatter-dot plot indicates distribution of cell length at cell division (mm; n  100). Black bars indicate mean values (mean+
s.e.: WT ¼ 14.0+ 0.1, as ¼ 17.2+ 0.3, asM17 ¼ 14.8+ 0.1, asM17 þ bsd ¼ 14.3+ 0.1). (c) OD (590 nm) measurement of log-phase cultures at 258C.
(d ) FACS results showing the DNA content of vegetative cells at 258C. For control of 1C DNA content, 12 mM HU was added to the WT culture (WT þ HU).
(e) Fivefold dilutions of the indicated strains were spotted onto the following media: YE containing 5 mM HU or 5 mM CPT, YE irradiated with 100 J m22
UV. Plates were incubated at the indicated temperature for 3–6 days.
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additional mutations to the cdc2-as gene containing the
open reading frame and 500 bp upstream and downstream
flanking regions (the strategy is summarized in the electronic
supplementary material, figure S1a). The amplified 2.2 kb
fragment was used for transformation of the original cdc2-as
mutant, selecting for colony formation at 368C (electronic
supplementary material, figure S1a,b). We expected that
these survivors should include intragenic suppressor
mutations. We chose 17 colonies that survived at 368C, and
restreaked onto the YE5S plate (rich medium) containing
phloxine B, which stains dead cells. Eight of 17 colonies
(named M1, M2, M6, M8, M10, M11, M12 and M17) grew
well at 368C as well as at 208C (electronic supplementary
material, figure S1b), therefore those candidates were neither
ts nor cs. Importantly, all of these survivors remained sensi-
tive to the ATP-analogue molecule 1NM-PP1 (electronicsupplementary material, figure S1b), indicating that none of
the survivors were revertants of the as mutation.
Based upon these assays, we retained the M17 mutant, in
which ts and cs phenotypes were significantly suppressed,
for further analyses (the mutant allele is called cdc2-asM17
hereafter; figure 1a). We next inserted the bsd gene (conferring
the blasticidin S resistance [48]) as the selection marker for the
modified cdc2-asM17 gene. The bsd gene was inserted at the
approximately 0.5 kb downstream of the termination codon
of the cdc2-asM17 gene (the allele is called cdc2-asM17 þ bsd
hereafter; figure 1a), and this did not affect the function of
Cdc2 (electronic supplementary material, figure S1b,c).
To validate cdc2-asM17 and cdc2-asM17þ bsd mutants as
new tools for general purposes, we evaluated whether they
behave normally in the absence of ATP-analogues, because the
original cdc2-as mutant is slightly deficient in cell cycle [17].
First, we measured the cell size of cdc2-asM17 (+bsd) mutants
(a)
(b) (c)
0
20
40
60
80
100
0
20
40
60
80
100
WT
no. nuclei no. spores
as asM17 asM17 + bsd WT as asM17 asM17 + bsd
WT
≥5
4
3
2
1c
el
ls 
(%
)
as asM17 asM17+bsd
D
IC
D
A
PI
≥5
4
3
2
1
0
Figure 2. Characterization of the cdc2-asM17 mutant in meiosis. (a) DAPI staining of cells that underwent mating, meiosis and sporulation. DAPI and differential
interference contrast (DIC) images are shown merged. Scale bar, 5 mm. (b,c) The numbers of (b) nuclei and (c) spores in each ascus shown in (a) were counted for
the indicated strains and the percentages are shown. (n . 200).
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longer than wild-type (WT) cells [17], indicating compromised
CDK activity. The elongation was not observed in the cdc2-
asM17 and cdc2-asM17 þ bsd strains. This was confirmed by a
growth curve assay of four strains (WT, cdc2-as, -asM17,
-asM17þ bsd; figure 1c): the growth of the cdc2-as strain was
slightly slower than WT, whereas the cdc2-asM17 and
-asM17þ bsd strains grew at the same rate asWT. Next, we per-
formed FACS analysis to examine the DNA content of cdc2-
asM17 mutants. As shown in figure 1d, cdc2-asM17 and
-asM17þ bsd mutants displayed similar DNA content profiles
compared with WT, indicating that cell cycle progression of
those mutants is similar to WT in the absence of the inhibitory
drug. Because the DNA structure check point depends upon
Cdc2 for activity, we examined whether cdc2-asM17 mutants
were sensitive to genotoxins. Although the original cdc2-as
strain was slightly sensitive to hydroxyurea (HU), UV and
camptothecin (CPT), the cdc2-asM17 strains were not (figure
1e). Finally, we investigated whether cdc2-asM17 remains
associated with Suc1 (p13suc1), which is known to interact
with the Cdc2-cyclin B complex [49]. A pulldown assay using
p13 Suc1-beads indicated that the cdc2-asM17mutation did not
affect interaction between CDK and Suc1, in the absence of
ATP-analogues (electronic supplementary material, figure S2).
Together the data described above, we demonstrate that
the cdc2-asM17 mutant (+bsd) behaves similarly to WT in
assays where the original cdc2-as allele shows clear defects,
thereby validating its use to study the role of Cdc2 activity
during mitotic cell cycle in several conditions where the orig-
inal cdc2-as was not functional. Insertion of the bsd marker
gene at the downstream of the cdc2 gene did not cause
abnormality as far as we have tested (figure 1b–e).
Next, we investigated if the cdc2-asM17mutant suppressed
the meiotic defects seen in the original cdc2-as mutant.
Homothallic h90 cdc2-asM17 cells underwent mating and
meiosis, and mostly generated four nuclei and four spores per
cell, as in WT, whereas the original cdc2-as cells generated
abnormal two or three nuclei and two or three spores [17]
(figure 2a–c). cdc2-asM17þ bsd also generated four nuclei
and four spores per cell (figure 2a–c). Spore viabilities ofcdc2-asM17 (91%, n ¼ 108) and cdc2-asM17 þ bsd (94%, n ¼
108) are comparablewith that ofWT (100%, n ¼ 104), indicating
that cdc2-asM17 and cdc2-asM17 þ bsd mutants undergo meio-
sis and produce viable spores to a similar extent to WT. Thus,
these mutants are suitable for analysis of Cdc2 functions in
meiosis, which could not be addressed using the original
cdc2-as mutant. Sporulation of five other suppressor mutants
(M1–M11) was also examined, and sporulation defects of the
original cdc2-as mutant were in general suppressed to some
extent (electronic supplementary material, figure S3).
3.2. Characterization of the suppressor mutations
We then sequenced the cdc2 gene of the suppressor mutants.
Interestingly, mutants M11 and M17 possessed mutations at
the same residue, lysine 79 (figure 3a). M11 had a substitution
of K79 to T (threonine), whereas M17 had a substitution of
K79 to E (glutamic acid). The mutation site was close to the
as mutation site F84G in the primary structure. M10 had a
substitution of glutamine at five to glutamic acid (Q5E).
To explore how the suppressor mutation in the mutant
M17 (K79E) suppressed the as mutation (F84G), the second-
ary and tertiary structure of the mutant protein was
subjected to the protein folding prediction program PHYRE2
(http://www.sbg.bio.ic.ac.uk/phyre2/) [50]. For the sake of
simplicity, we used amino acid residues 1–149 (from the
N-terminus to the b7 sheet), which form the N-terminal lobe
of the kinase [51]. Introduction of the analogue-sensitive
mutation F84Gwas predicted to generate a structural alteration
around theATP binding pocket (Cdc2-as; figure 3b). The defor-
mation of the ATP binding pocket was suppressed by the
additional introduction of K79E (Cdc2-asM17; figure 3b).
Consistent with this result, mutations within a b sheet in the
N-terminal lobe have been reported to suppress the gatekeeper
mutations that are not tolerated in several kinases [52]. It is
possible that the introduction of K79E, which locates at the
edge of the b sheet, may twist the sheet, so that the opposite
edge of the sheet harbouring F84G alters the angle at the
ATP-binding pocket. Kinase assays of WT Cdc2 and Cdc2-
asM17 revealed that the activity of asM17, but not of WT
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Figure 3. Intragenic suppressor mutations of the isolated cdc2 mutants. (a) The schematic of the cdc2 gene. The analogue-sensitive mutation is F84G [17]. The suppressor
mutant M10 contained the Q5E substitution. The M11 and M17 mutants shared the mutation site K79 to T (M11) and to E (M17) in the open reading frame of the cdc2
gene, in addition to the F84G mutation. (b) The prediction of secondary and tertiary structure of Cdc2 WT (wild-type), Cdc2-as and Cdc2-asM17 proteins made by the PHYRE
program. (i) Magnified view around the ATP-binding pocket and the gatekeeper residue F84 (or F84G). (ii) The overview for (i). The mutation site K79E and a reference site
E77 are shown with red asterisks, and F84G is shown with black asterisks. (c) In vitro kinase assay using Cdc2 WT and Cdc2-asM17 proteins purified from WT and the
mutant strains, respectively. The Cdk1 substrate histone H1 was incubated with purified Cdc2 proteins and [32P]-a-ATP in the indicated concentration of 1NM-PP1.
Autoradiograph images with a short and long exposure are shown. CBB; Coomassie brilliant blue straining for the loading control. Arrowheads indicate the position
of histone H1, and the asterisk band corresponds to GST-tagged p13Suc1 derived from Suc1-beads used in affinity purification.
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analogue 1NM-PP1 (figure 3c). Although the suppressor
mutation rescues all the phenotypic defects of cdc2-as, the
in vitro kinase assay nonetheless reveals that Cdc2-asM17 is
less active thanWTCdc2 in the absence of 1NM-PP1 (figure 3c).3.3. Cdc2 and the SAC: the use of cdc2-asM17 with
MBC or the b-tubulin ts mutant
Elevation of the Cdc2 kinase activity induces assembly of
the bipolar spindle at mitotic onset. If microtubule formation
is perturbed by internal mutations or drugs, then theattachment of kinetochores to microtubules may be inhibited.
The spindle assembly checkpoint (SAC) monitors kineto-
chore–microtubule attachment to ensure faithful chromosome
segregation in mitosis. The SAC components Mad1–Mad2
recognize unattached kinetochores and arrest cell cycle pro-
gression at metaphase until correct attachment has been
accomplished. Recent studies in yeast, flies, frogs and humans
have suggested that Cdk1 can serve as an upstream activator
of the SAC [53–58]. We therefore used the cdc2-asM17 mutant
to examine whether CDK activity is required to maintain an
SAC arrest in S. pombe.
First, we tested whether the microtubule drug methyl
benzimidazol-2-yl-carbamate (MBC) induces cdc2-as cells to
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tive to a low concentration of MBC (10 mg ml21), which did
not prevent colony formation in WT cells (figure 4a). By
contrast, the cdc2-asM17 mutant was not sensitive to MBC
(figure 4a). We therefore constructed the cdc2-asM17 strain
expressing Mad2-GFP, the kinetochore marker Mis6-2mRFP
and the SPB marker Sid4-2ECFP. Cells were treated with
MBC to induce metaphase arrest; bright Mad2-GFP signal
was observed at kinetochores, which is a hallmark of SAC
activation (21 min, figure 4b). Cells were then filmed and
1NM-PP1 or DMSO was added to the medium (0 min,
figure 4b). In the DMSO treatment, Mad2-GFP dots remained
at kinetochores for longer than 15 min (þDMSO, figure 4b,d).
By contrast, Mad2-GFP dots mostly disappeared within
4 min after 1NM-PP1 addition (þ1NM-PP1, figure 4b,d).
This demonstrates that Cdc2 kinase activity is required
for maintenance of SAC activation in the presence of
microtubule perturbation, through Mad2 recruitment tokinetochores. A very recent study in human cells
has shown that Mad2 recruitment to kinetochore requires
Cdk1 activity [59], suggesting that this mechanism has been
conserved through evolution.
We examined this further using the ts b-tubulin mutant
nda3/alp12-1828, which was impossible to combine with
the original cdc2-as mutant, because the long G2-phase of
S. pombe results in a predominant G2-arrest owing to temp-
erature sensitivity of the cdc2-as allele. After shift to 368C,
the nda3-1828 cdc2-asM17 mutant efficiently arrested at pro-
metaphase without a spindle, and Mad2-GFP dots were
associated with kinetochores (21 min, figure 4c). In the pres-
ence of 1NM-PP1, Mad2-GFP dots mostly disappeared
within 4 min (þ1NM-PP1, figure 4c,d), confirming that SAC
maintenance requires Cdc2 activity during mitosis. These
experiments also demonstrate the utility of the analogue-
sensitive mutant cdc2-asM17 to investigate the involvement
of Cdc2 in mitotic events such as the SAC.
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the b-tubulin cs mutant
Recently, it was reported that SAC silencing (inactivation)
during mitosis is achieved by the protein phosphatase
PP1 [60–63]. The fission yeast has two PP1 phosphatases,
Dis2 and Sds21 [64,65], though only Dis2 has a function
in SAC silencing [61]. To test whether Dis2/PP1 is required
for the SAC silencing following Cdc2 inactivation (as
shown in figure 4), we created the double mutant cdc2-
asM17 nda3-KM311. The double mutant of the original
cdc2-as and nda3-KM311 did not enter mitosis efficiently,
owing to the cold-sensitivity of cdc2-as [17]. By contrast,
the cdc2-asM17 nda3-KM311 cells arrested efficiently in
mitosis at 188C with a strong nuclear signal of cyclin B/
Cdc13-YFP, (0 min, figure 5a,c). When 1NM-PP1 was
added to the medium, the frequency of cells harbouring
Cdc13-YFP signal decreased (60 min, figure 5a,c). In con-
trast, when the dis2þ gene was disrupted, the triple
mutant dis2D nda3-KM311 cdc2-asM17 retained a Cdc13-
YFP signal even after addition of 1NM-PP1 (figure 5b,c).
This indicates that Cdc2 andDis2/PP1 are required tomaintain
and silence the checkpoint machinery, respectively. Ark1/
aurora B kinase, a component of the CPC, is also required for
SAC maintenance [61]. As centromere targeting of CPC
depends on Cdk1 [23], maintenance of the SAC by Cdc2
might be achieved through the control of CPC localization to
centromeres. Alternatively, Cdc2 might regulate the SAC inde-
pendently of CPC localization, because centromeric retention
of CPC in anaphase does not result in APC/C inhibition
(SAC activation) in human cells [66]. How Dis2 /PP1 counter-
acts Cdc2 in SAC silencing is an important question and will
be addressed in future studies. The dis2D nda3-KM311 cdc2-
asM17 mutant frequently resulted in unequal chromosome
segregation with persistent nuclear Cdc13-YFP (figure 5b),
indicating that checkpoint adaptation (slippage into anaphase)
may occur evenwithout complete cyclin destruction, when the
Cdc2 activity is inhibited.3.5. Shugoshin and Cdc2: the use of cdc2-asM17
in meiosis
Genetic perturbation of Cdc2 prevents entry into meiosis I
[67], making it difficult to examine the function of Cdc2 in
spindle organization and chromosome segregation during
meiosis I. Because the cdc2-asM17 strain does not show meio-
tic defects in the absence of ATP-analogues we used it to
address this question.
We have previously used cdc2-asM17 strain to show that
reorganization of SPBs at the onset of meiosis I requires
Cdc2 activity [68]. We have now used it to examine the role
of Cdc2 activity at the metaphase–anaphase transition in
meiosis I. To ensure faithful segregation of chromosomes
during meiosis I, proteins such as aurora B and protein
phosphatase 2A (PP2A) are localized transiently to centro-
meres, until the onset of anaphase I [69,70]. It is unclear
whether delocalization of aurora B and PP2A at the onset
of anaphase I depends on reduction of the Cdc2 activity or
proteasome-dependent protein degradation.
To distinguish these two possibilities, we used slp1-s.o.
cut23-s.o. mutations, in which meiotic expression of the APC/
C component Cut23 and its activator Slp1 is repressed [71],
thereby preventing proteasome-dependent protein degra-
dation. Then, 1NM-PP1 was added to inhibit Cdc2 activity of
cdc2-asM17 cells. First, we examined localization of Ark1
(aurora B). Cdc2 phosphorylates the CPC component Bir1/
survivin to recruit Ark1 to centromeres in fission yeast mitosis
[23], but it has not been tested whether this mechanism is con-
served during meiosis. Ark1 localized to centromeres in cells
arrested in metaphase I, and delocalized from centromeres
when Cdc2 activity was reduced by addition of 1NM-PP1
(figure 6a). This indicates thatdelocalizationofArk1 fromcentro-
meres depends on reduction of the Cdc2 activity, but not on
degradation of CPC components. Second, we examined the
localization of Shugoshin (Sgo1), which forms a complex with
PP2Aand is essential for its localizationat centromeres [70].Con-
sistent with previous studies [69], Sgo1 localized to centromeres
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localization at centromeres even when Cdc2 activity was
decreased by 1NM-PP1 (figure 6b). Thus, maintenance of the
Sgo1 localization at centromeres does not require Cdc2 activity,
raising the possibility that APC-mediated Sgo1 degradation
might be a trigger of Sgo1 delocalization from centromeres.4. Conclusion
The generation of an analogue-sensitive mutant is a powerful
tool that enables chemical inhibition of any kinase of interest.
In general, analogue sensitivity is conferred by introducing a
single amino acid substitution of the ‘gatekeeper’ residue in
the active site. This sometimes causes a partial loss of
kinase function, as in the case of the cdc2-as mutant [17].
The original cdc2-as mutant (F84G) showed defects in
growth at high and low temperature and in meiosis. We
have used natural selection to suppress these defects, which
occurred through an additional mutation at K79E, to generate
the cdc2-asM17 mutant.A systematic generation of analogue-sensitive mutants of
all essential kinases in fission yeast found that three (of 16)
essential kinases could not be generated (Cdc7, Hsk1 and
Sid1), because an introduction of the analogue-sensitive
mutation caused a significant loss of function [7]. For instance,
it was impossible to create the sid1-asmutant, because replace-
ment of the wild-type sid1þ with the sid1-as mutant gene
caused lethality (Y.A., S.A.K., V.S., M.Y. & M.S. 2011, unpub-
lished data). Those issues, however, might be solved by
applying the method described in this study. Specifically, if
the gatekeeper mutation resides at the end of a b sheet, then
the suppressor mutation could be introduced at the opposite
end of the sheet (figure 3a,b). Alternatively, it might be more
judicious to allow in vivo selection to generate the required
mutant, as we have done here (electronic supplementary
material, figure S1a). The library of mutagenized DNA frag-
ments could be used for transformation of the existing ts (or
other) mutant of the kinase. Transformants viable at the restric-
tive temperature should contain the suppressor mutation in
addition to the gatekeeper mutation.
The in vivo selected cdc2-asM17 mutant permitted us to
undertake experiments that were not possible previously, such
Table 1. Strains used in this study. The origin of the strains is this study, except for JY878 and SP5959 (our stock) and PY328 (a gift from Y. Watanabe).
strain genotype ﬁgures
MJ1172 h90 sﬁ1-CFP-nat leu1–32 ura4-D18 ade6-M216 1b–e, 2a–c and electronic supplementary
material, ﬁgure S2
MJ1254 h90 cdc2-as sﬁ1-CFP-nat leu1–32 ura4-D18 ade6-M216 1b–e, 2a–c and electronic supplementary
material, ﬁgures S1a–c, S2 and S3a–c
MJ1353 h90 cdc2-asM17 sﬁ1-CFP leu1–32 ura4-D18 ade6-M216 1b–e, 2a–c and electronic supplementary
material, ﬁgures S1b,c, S2 and S3a–c
MJ1358 h90 cdc2-asM17-bsd sﬁ1-CFP-nat leu1–32 ura4-D18 ade6-M216 1b–e, 2a–c, 3c, 4a and electronic supplementary
material, ﬁgures S1c and S2
PY328 h90 rad3 ::LEU2þ leu1–32 ura4-D18 ade6-M210 1e
SAK1 hþ leu1–32 ura4-D18 ade6-M216 3c
MJ1360 h90 cdc2-as-bsd sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 4a and electronic supplementary material,
ﬁgure S1c
YA1843 h90 cdc2asM17bsd mad2GFPkan mis62mRFPhph sid42ECFPnat leu132 ura4D18 4b,d
YA1829 h90 cdc2asM17bsd nda3(alp12)1828 mad2GFPkan mis62mRFPhph sid42ECFPnat
leu132 ura4D18 ade6M216
4c,d
YA1900 h90 cdc2asM17bsd nda3KM311 cdc13YFPTcdc13kan sid42ECFPnat leu132 ura4D18
ade6
5a,c
YA1893 h90 cdc2asM17bsd nda3KM311 dis2::ura4þ cdc13YFPTcdc13kan sid42ECFPnat
leu132 ura4D18 ade6
5b,c
SAK422 h90 cdc2-asM17-bsd ark1-GFPFH-kan Prad21-slp1-kan Prad21-cut23-kan
z::Padh15-mcherry-atb2-nat leu1-32 ade6-M216
6a
SAK420 h90 cdc2-asM17-bsd sgo1þ-ﬂag-GFP par1–mCherry-hyg Prad21-slp1-kan
Prad21-cut23-kan z::Padh13-CFP-atb2-nat leu1-32 ade6-M216
6b
JY878 h90 leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgures S1b,c
and S3a
SP5959 h – cdc2-as ura4-D18 electronic supplementary material, ﬁgure S1a
MJ1346 h90 cdc2-asM1 sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgure S1b
MJ1347 h90 cdc2-asM2 sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgure S1b
MJ1348 h90 cdc2-asM6 sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgures S1b and
S3a
MJ1349 h90 cdc2-asM8 sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgures S1b and
S3a–c
MJ1350 h90 cdc2-asM10 sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgures S1b,c
and S3a–c
MJ1351 h90 cdc2-asM11 sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgures S1b,c
and S3a–c
MJ1352 h90 cdc2-asM12 sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgure S1b
MJ1356 h90 cdc2-asM10-bsd sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgure S1c
MJ1357 h90 cdc2-asM11-bsd sﬁ1-CFP-nat leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgure S1c
MJ1359 h90 cdc2þ-bsd leu1-32 ura4-D18 ade6-M216 electronic supplementary material, ﬁgure S1c
SAK163 h – cdc2-33 electronic supplementary material, ﬁgure S2
MO1893 h90 cdc2-asM17-bsd leu1-32 ura4-D18 ade6-M216 Methods
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temperatures, and during meiosis. This mutant has revealed
an important role of Cdc2/Cdk1 in SAC maintenance, and the
dispensability of Cdc2/Cdk1 for localization of Shugoshin inmeiosis. Although mitotic kinases represented by Cdk1, Polo
and aurora regulate many aspects of mitosis and meiosis, the
availability of this chemical genetic tool will allow us to increase
our understanding of the role of Cdc2/CDK1.
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5.1. Yeast genetics and general manipulations
The strains used in this study are listed in table 1. We used
standard methods for fission yeast genetics, as described pre-
viously [72]. Tagging of a single copy of a fluorescent protein
(GFP) at the C-terminus of genes, and insertion of the bsd
marker gene, was performed using standard PCR-based
methods [73,74]. Tagging of multiple tandem copies of fluor-
escent proteins (2mRFP and 2ECFP) at the C-terminus of
genes was performed as previously described [34]. All the
fluorescent protein-fused genes are expressed by the native
promoter and the adh terminator [73], except for cdc13-YFP,
mCherry-atb2 and CFP-atb2 fusion genes. The cdc13-YFP
fusion gene is expressed by the cdc13þ promoter and termin-
ator. The mCherry-atb2 gene is expressed by the Padh15
promoter and the adh terminator, and the CFP-atb2 gene is
expressed by the Padh13 promoter and the adh terminator
[75]. 1NM-PP1 (Calbiochem, CA) was added to media at
the concentration of 2 mM. For figure 1b, living cells were
stained with Calcofluor (Sigma, MO), and the cell length
was measured on the IMAGEJ software (NIH). For the FACS
analysis in figure 1d, the DNA content was measured using
BD FACSCalibur (BD, NJ). For figure 2a–c, homothallic h90
cells were induced to mating, meiosis and sporulation on
sporulation agar plates. After incubation for 24 h at 308C,
cells were fixed with methanol and stained with 40,6-diami-
dino-2-phenylindole (DAPI; Wako Pure Chemicals, Japan),
and the number of nuclei and spores in each ascus were
counted. For the spore viability assay, spores were dissected
by the micromanipulator (Singer Instruments, Somerset, UK),
and the percentage of spores that formed colonies was calcu-
lated. The checkpoint silencing assay in figure 5 was
performed as previously described [61]. The prometaphase-
arrested nda3-KM311 cells at 188C were treated with 1 mM
1NM-PP1 or DMSO. Cells were collected at the indicated
time point, fixed with methanol and stained with DAPI
(Wako Pure Chemicals).
5.2. Creation of the cdc2-asM17 mutant
The creation of the original cdc2-asmutant has been described
previously [17]. A flow chart for the method to generate the
cdc2-asM17 mutant is depicted in the electronic supplemen-
tary material, figure S1a. Briefly, the genomic cdc2-as
mutant gene was amplified from the original mutant [17].
The coding region of cdc2-as with flanking 0.5 kb up/down-
stream regions at both ends (in total 2.2 kb; electronic
supplementary material, figure S1a) was amplified by a stan-
dard PCR method with PrimeSTAR HS DNA polymerase
(Takara-Bio, Japan). The amplified fragment was gel-purified,
and used as the template for the following error-prone PCR.
To induce errors, thermal cycling was performed for 40 cycles
using the Ex Taq polymerase (Takara-Bio) and the same pair
of oligomers used for the first PCR. The amplified fragments
were then used for transformation of the cdc2-as sfi1-CFP-nat
strain MJ1254 (Sfi1-CFP is an SPB marker). Colonies that
grew at 368C were restreaked onto YE5S plates containing
Phloxin B, to visualize suppression of temperature sensitivity.
Cold sensitivity was also tested at 208C. Confirmation of the
analogue sensitivity was done with YE5S plates containing10 mM 1NM-PP1. The bsd marker gene was inserted 528 bp
downstream of the termination codon of the cdc2 gene. For
figures 3–6, the cdc2-asM17 mutant with bsd insertion was
used and denoted as cdc2-asM17 for simplicity. The sfi1-CFP
SPB marker was removed through backcrossing of the cdc2-
asM17-bsd sfi1-CFP-nat strain (MJ1358) with a wild-type
strain without markers, to yield MO1893.
5.3. Microscopy
Images in figures 1b and 2awere acquired using an Axio Ima-
ger.M2 fluorescence microscope and AXIOVISION software
(Zeiss, Germany). Live-cell imaging methods for figure 4
were described previously [34]. Briefly, live-cell imaging
was performed with the DeltaVision-SoftWoRx system (GE
Healthcare, UK). Cultured cells were mounted on a glass-
bottom dish (Matsunami, Japan) coated with lectin and
filled with minimal medium. Serial section images along
the z-axis were acquired and stacked using the ‘quick projec-
tion’ protocol in SOFTWORX. Temperature-sensitive strains
were observed in a temperature-controlled chamber to main-
tain 368C during observation. MBC (carbendazim; Sigma,
MO) was added to liquid culture at the final concentration
of 50 mg ml21 [76]. 2 mM 1NM-PP1 or DMSO was added to
liquid media during observation. Images in figure 5 and elec-
tronic supplementary material, figure S3a were acquired by
an Axioplan 2 fluorescence microscope (Zeiss) and SLIDEBOOK
software (Leeds Precision, UK). Images in figure 6 were taken
as described previously [77].
5.4. In vitro kinase assay and Western blotting
Schizosaccharomyces pombe protein extract from wild-type and
cdc2-asM17 cells was prepared, and the Cdc2–Cdc13 complex
was purified using Suc1-beads (Millipore, MA). The pull-
downs containing Cdc2–Cdc13 were mixed with histone
H1 (New England BioLabs, UK) as a substrate, in the absence
or presence of 1NM-PP1 (0–103 nM). Samples were subjected
to SDS–PAGE, and the gel was stained with Coomassie bril-
liant blue followed by autoradiography. For Western blotting
in electronic supplementary material, figure S2, extracts or
pulldowns by Suc1-beads were subjected to SDS–PAGE.
The following antibodies were used: anti-Cdc2 monoclonal
(1 : 1000; a gift from Y. Watanabe) and anti-tubulin monoclonal
TAT-1 (1 : 5000; a gift from K. Gull).
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